EUVIMEDEUVIMED entdecken
Übersichtsarbeit

GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing

Johanna Ghebrehiwet-Kuflom, Alisha Mehta, Pallas Lim, Sara Dahle, R Rivkah Isseroff

Journal of Investigative Dermatology · 2025-12 · 145 (12) · 2981-2988

DOI: 10.1016/j.jid.2025.08.045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Investigative Dermatology, 2025-12. Verfasst von Johanna Ghebrehiwet-Kuflom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA; Dermatology Section, VA Northern California He…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Wound Healing, Diabetic Foot, Neovascularization, Physiologic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcers (DFUs) represent a clinically burdensome and pathophysiologically distinct complication of diabetes mellitus, marked by persistent inflammation, dysregulated immune signaling, impaired angiogenesis, and delayed re-epithelialization. Despite adherence to standardized wound care protocols, DFUs remain recalcitrant to healing, contributing to high rates of recurrence, infection, and lower extremity amputation. Although established in glycemic control, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exert pleiotropic immunomodulatory and regenerative effects relevant to cutaneous repair. This narrative review summarizes mechanistic insights derived from in vitro and animal models through which GLP-1 RA may suppress TNF-α and NF-κB signaling; activate adenosine monophosphate-activated protein kinase and phosphoinositide 3-kinase/protein kinase B pathways; and promote keratinocyte migration, endothelial progenitor cell function, and macrophage polarization toward reparative phenotypes. Additional mechanisms include restoration of neutrophil antimicrobial function, modulation of matrix remodeling, and upregulation of angiogenic mediators such as VEGFR-2 and HIF-1α. Preclinical findings suggest that these agents may address key barriers to wound healing. While preliminary findings are promising, clinical trials comparing GLP-1 RA therapy with standard of care are needed. Although still investigational, the topical formulation could expand therapeutic applicability if supported by additional clinical evidence. Given their immunomodulatory and tissue-regenerative properties, GLP-1 RAs may represent an adjunctive therapy for DFUs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsWound HealingDiabetic FootNeovascularization, PhysiologicHumansAnimalsInflammationSkinSignal TransductionAngiogenesis

Stichwörter der Autor:innen

AngiogenesisChronic woundDiabetic foot ulcerGLP-1 receptor agonistInflammation

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA; Dermatology Section, VA Northern California Health Care System, Sacramento, California, USA.
  • Dermatology Section, VA Northern California Health Care System, Sacramento, California, USA; College of Medicine, California Northstate University, Elk Grove, California, USA.
  • Dermatology Section, VA Northern California Health Care System, Sacramento, California, USA.
  • Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA; Podiatry Section, Surgical Services, VA Northern California Health Care System, Sacramento, California, USA.
  • Department of Dermatology, University of California Davis Medical Center, Sacramento, California, USA; Dermatology Section, VA Northern California Health Care System, Sacramento, California, USA. Electronic address: rri…

Zitieren

APA

Ghebrehiwet-Kuflom, J., Mehta, A., Lim, P., Dahle, S., & Isseroff, R. R. (2025). GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing. Journal of Investigative Dermatology, 145(12), 2981-2988. https://doi.org/10.1016/j.jid.2025.08.045

Vancouver

Ghebrehiwet-Kuflom J, Mehta A, Lim P, Dahle S, Isseroff RR. GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing. Journal of Investigative Dermatology. 2025;145(12):2981-2988. doi:10.1016/j.jid.2025.08.045

BibTeX
@article{GhebrehiwetKuflom2025,
  author = {Ghebrehiwet-Kuflom, Johanna and Mehta, Alisha and Lim, Pallas and Dahle, Sara and Isseroff, R Rivkah},
  title = {GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {12},
  pages = {2981--2988},
  doi = {10.1016/j.jid.2025.08.045}
}
Kostenlos starten →